Celebrities on cancer
Cindy Crawford’s cancer fears over signature facial mole
Her face is well-known all over the world, including the mole that adorns one corner of her mouth. Cindy Crawford’s signature facial mark is part of natural beauty and a source of fear for the super model. The mole started as a freckle and has grown since then. 43-year old Crawford tells the Daily News she has her facial mole and many others which are less visible regularly checked by doctors in case they turn malignant. She also says she pays close attention to her health, only drinking occasionally and never smoking.
Ex Drummer Of Rock Band KISS Speaks In Public About His Breast Cancer
Peter Criss is the ex drummer of the rock band KISS talks openly about his breast cancer experience. In support of National Breast Cancer Awareness month, the 63-year old musician revealed that he was diagnosed with breast cancer and successfully treated last year. Breast cancer is very common in women but rare in men (less than 1%).
FDA cancer approvals
FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys
Gardasil can also now be used for boys. The US FDA has recently approved the vaccine for boys and men ages boys and men, ages 9 through 26. Vaccination in boys is recommended for the prevention of genital warts (condyloma acuminata) caused by human papillomavirus (HPV) types 6 and 11. Genital warts can later on lead to genital cancer. In addition, HPV is sexually transmitted and male partners may pass on the virus to female partners and thereby increasing their risks cervical, vulvar and vaginal cancers. Gardasil is already approved for use in girls staring at age 11 to prevent infection due to HPV types 6, 11, 16, and 18. It is manufactured by Merck.
FDA Approves New Vaccine for Prevention of Cervical Cancer
Cervarix is another vaccine against HPV. It has recently been approved for the prevention of genital infections cause by HPV types 16 and 18 in girls and women ages 10 through 25 years of age. Cervarix is manufactured by the UK-based GlaxoSmithKline Biologicals. It has already been used in the UK since last year. According to Dr. Karen Midthun, acting director of the FDA’s Center for Biologics Evaluation and Research.
“The licensure of Cervarix adds another option in the prevention of cervical cancer. It has the potential to save lives from cervical cancer as well as reduce the need for biopsies and invasive procedures associated with the necessary follow-up from abnormal Pap tests.”
FDA Approves New Treatment for Advanced Form of Kidney Cancer
Another FDA approval this week is for Votrient (pazopanib) for the treatment of advanced kidney cancer. Votrient is taken orally and “is intended for people with advanced renal cell carcinoma, a type of kidney cancer in which the cancerous cells are found in the lining of very small tubes (tubules) in the kidney.” Votrient is manufactured by GlaxoSmithKline based in the UK.
Photo credit: stock.xchng